HORIZON PHARMA PLC's ticker is HZNPXXXX and the CUSIP is G4617B105. A total of 201 filers reported holding HORIZON PHARMA PLC in Q2 2016. The put-call ratio across all filers is 0.33 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $2,010,000 | +9.4% | 76,053 | -19.1% | 0.02% | +14.3% |
Q4 2018 | $1,837,000 | -54.4% | 94,000 | -54.3% | 0.01% | -33.3% |
Q3 2018 | $4,030,000 | -14.3% | 205,800 | -27.5% | 0.02% | -19.2% |
Q2 2018 | $4,702,000 | +99.4% | 283,911 | +71.0% | 0.03% | +100.0% |
Q1 2018 | $2,358,000 | +56.0% | 166,014 | +60.1% | 0.01% | +85.7% |
Q4 2017 | $1,512,000 | -33.9% | 103,715 | -42.5% | 0.01% | -41.7% |
Q3 2017 | $2,287,000 | +337.3% | 180,400 | +308.6% | 0.01% | +300.0% |
Q2 2017 | $523,000 | -56.6% | 44,150 | -46.0% | 0.00% | -62.5% |
Q1 2017 | $1,205,000 | -33.2% | 81,688 | -26.7% | 0.01% | -38.5% |
Q4 2016 | $1,804,000 | +17.1% | 111,388 | +31.2% | 0.01% | +18.2% |
Q3 2016 | $1,541,000 | -1.3% | 84,891 | -10.5% | 0.01% | +10.0% |
Q2 2016 | $1,562,000 | +121.9% | 94,891 | +123.6% | 0.01% | +42.9% |
Q1 2016 | $704,000 | +15.4% | 42,437 | +51.6% | 0.01% | +16.7% |
Q4 2015 | $610,000 | +133.7% | 28,000 | +113.7% | 0.01% | +100.0% |
Q3 2015 | $261,000 | -47.3% | 13,100 | -8.1% | 0.00% | -50.0% |
Q2 2015 | $495,000 | – | 14,251 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
JABODON PT CO | 187,808 | $4,519,000 | 3.52% |
KNOTT DAVID M | 50,046 | $1,204,000 | 0.51% |
CASTLEARK MANAGEMENT LLC | 362,980 | $8,733,000 | 0.34% |
EAGLE ASSET MANAGEMENT INC | 2,692,100 | $64,771,000 | 0.33% |
USA FINANCIAL FORMULAS | 15,202 | $402,000 | 0.20% |
Qtron Investments LLC | 12,274 | $295,000 | 0.18% |
C WorldWide Group Holding A/S | 491,544 | $11,827,000 | 0.15% |
Gotham Asset Management, LLC | 207,158 | $4,984,000 | 0.08% |
Russell Investments Group, Ltd. | 608,977 | $14,652,000 | 0.03% |
FNY Investment Advisers, LLC | 3,350 | $80,000 | 0.02% |